Search Results 811-820 of 23722 for autoimmune hepatitis

1. Medical Research & Education - Mayo Clinic News Network

   April 1, 2024. Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases featured image. Research. Mayo Clinic scientists pioneer ...

2. Medical Research & Education - Mayo Clinic News Network

   Mayo Clinic researchers have pinpointed how excessive alcohol consumption contributes to fatty liver disease. Latest stories. AI applied to prediagnostic CTs ...

3. A Study Of Obeticholic Acid Evaluating Clinical Outcomes In Patients With Primary Biliary Cirrhosis

   Primary biliary cirrhosis is a serious, life-threatening, bile acid related liver disease of unknown cause. Without treatment, it frequently progresses to liver ...

4. Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis - Mayo Clinic

   Alcoholic liver disease. 4. Autoimmune hepatitis (AIH) indicative of PBC with overlap syndrome. Note: The Paris criteria are commonly used to define the ...

5. Alcohol-related liver disease / cardio-oncology / lifestyle factors and the brain - Mayo Clinic News Network

   Alcohol-related liver disease / cardio-oncology / lifestyle factors and the brain. June 29, 2019. Related Episodes.

6. Videos - Biliary Regenerative Medicine: Robert C. Huebert - Mayo Clinic Research

   Robert C. Huebert, M.D., and Jorge Rakela, M.D., of Mayo Clinic discuss the regenerative properties of the liver to help those with chronic liver disease.

7. Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of ANX005 In Subjects With Warm Autoimmune Hemolytic Anemia (WAIHA) - Mayo Clinic

   The purpose of this study is to evaluate the safety and tolerability of ANX005 in participants with Warm Autoimmune Hemolytic Anemia (wAIHA). Participation ...

8. Liver fibrosis - Care at Mayo Clinic

   Mayo Clinic specialists have extensive experience evaluating and caring for people with chronic liver disease, including liver fibrosis. Each year ...

9. Autoimmune Diseases of the Blood and Blood Cells - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. A Study of the Effectiveness and Safety of Subcutaneous Semaglutide for Patients with Fatty-Liver Disease, not Caused by Alcoholism - Mayo Clinic

    A Study of the Effectiveness and Safety of Subcutaneous Semaglutide for Patients with Fatty-Liver Disease, not Caused by Alcoholism · More about research at Mayo ...